Skip to main content
. 2002 Nov 4;87(10):1145–1152. doi: 10.1038/sj.bjc.6600578

Figure 2.

Figure 2

Overall survival rate according to the status of COX-2 in tumour cells (A), in stroma inflammatory cells (B), and according to the ratio between tumour/stroma COX-2 IDV (C) in 99 cervical cancer patients.